These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19320052)

  • 1. Rota and pneumococcus vaccine success stories: pediatric emergency practitioners wonder "where have the kids gone?".
    McKenna M
    Ann Emerg Med; 2009 Apr; 53(4):23A-25A. PubMed ID: 19320052
    [No Abstract]   [Full Text] [Related]  

  • 2. Cocontribution of Rotavirus and Pneumococcal Conjugate Vaccines to the Reduction of Pediatric Hospital Visits in Young Children.
    Ben-Shimol S; Givon-Lavi N; Greenberg D; Dagan R
    J Pediatr; 2017 Mar; 182():253-259.e2. PubMed ID: 27939127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ghana and Rwanda expand national immunization programs.
    Riedmann EM
    Hum Vaccin Immunother; 2012 Jul; 8(7):848. PubMed ID: 23213664
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of pneumococcal conjugate vaccine and rotavirus vaccine introduction into the South African public immunisation programme.
    Madhi SA; Bamford L; Ngcobo N
    S Afr Med J; 2014 Mar; 104(3 Suppl 1):228-34. PubMed ID: 24893498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Projected health benefits and costs of pneumococcal and rotavirus vaccination in Uganda.
    Tate JE; Kisakye A; Mugyenyi P; Kizza D; Odiit A; Braka F
    Vaccine; 2011 Apr; 29(17):3329-34. PubMed ID: 21241733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global Rotavirus and Pneumococcal Conjugate Vaccine Introductions and the Association With Country Disease Surveillance, 2006-2018.
    Peck ME; Hampton LM; Antoni S; Ogbuanu I; Serhan F; Nakamura T; Walldorf JA; Cohen AL
    J Infect Dis; 2021 Sep; 224(12 Suppl 2):S184-S193. PubMed ID: 34469564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current immunization policies for pneumococcal, meningococcal C, varicella and rotavirus vaccinations in Italy.
    Alfonsi V; D'Ancona F; Giambi C; Nacca G; Rota MC;
    Health Policy; 2011 Dec; 103(2-3):176-83. PubMed ID: 22030308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods and challenges in measuring the impact of national pneumococcal and rotavirus vaccine introduction on morbidity and mortality in Malawi.
    Bar-Zeev N; Kapanda L; King C; Beard J; Phiri T; Mvula H; Crampin AC; Mwansambo C; Costello A; Parashar U; Tate JE; Verani JR; Whitney CG; Heyderman RS; Cunliffe NA; French N;
    Vaccine; 2015 May; 33(23):2637-45. PubMed ID: 25917672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of using 13-valent pneumococcal vaccine in American children (and adults)].
    Seguí Díaz M
    Semergen; 2016; 42(1):49-51. PubMed ID: 26026361
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevnar--will it be the next vaccine success story?
    Fiechtner HB
    S D J Med; 2003 Sep; 56(9):377-8. PubMed ID: 14524137
    [No Abstract]   [Full Text] [Related]  

  • 11. Rotavirus Infection: A Disease of the Past?
    Dennehy PH
    Infect Dis Clin North Am; 2015 Dec; 29(4):617-35. PubMed ID: 26337738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergency department epidemiology of pneumococcal bacteremia in children since the institution of widespread PCV7 vaccination.
    Mistry RD; Wedin T; Balamuth F; McGowan KL; Ellison AM; Nelson KA; McLoughlin RJ; Alpern ER
    J Emerg Med; 2013 Dec; 45(6):813-20. PubMed ID: 23992851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A major outbreak of gastroenteritis in Réunion Island in 2012: first identification of G12 rotavirus on the Island.
    Caillère N; Vilain P; Brottet E; Kaplon J; Ambert-Balay K; Polycarpe D; Filleul L
    Euro Surveill; 2013 May; 18(19):20476. PubMed ID: 23725808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal Immunity and acute viral gastroenteritis.
    Rose MA
    Hum Vaccin Immunother; 2014; 10(7):2112-4. PubMed ID: 25424826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction.
    Hull JJ; Teel EN; Kerin TK; Freeman MM; Esona MD; Gentsch JR; Cortese MM; Parashar UD; Glass RI; Bowen MD;
    Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S42-7. PubMed ID: 21183839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The composition of demand for newly launched vaccines: results from the pneumococcal and rotavirus vaccine introductions in Ethiopia and Malawi.
    Williams BA; Kidane T; Chirwa G; Tesfaye N; Prescott MR; Scotney ST; Valle M; Abebe S; Tambuli A; Malewezi B; Mohammed T; Kobayashi E; Wootton E; Wong R; Dosani R; Subramaniam H; Joseph J; Yavuz E; Apple A; Le Tallec Y; Kang'ethe A
    Health Policy Plan; 2016 Jun; 31(5):563-72. PubMed ID: 26856361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. US study suggests universal vaccination of children with pneumococcal conjugate vaccine is beneficial for adults.
    Doroshenko A
    Euro Surveill; 2005 Nov; 10(11):E051124.4. PubMed ID: 16794287
    [No Abstract]   [Full Text] [Related]  

  • 18. Decline in Emergency Department Visits for Acute Gastroenteritis Among Children in 10 US States After Implementation of Rotavirus Vaccination, 2003 to 2013.
    Shah MP; Tate JE; Steiner CA; Parashar UD
    Pediatr Infect Dis J; 2016 Jul; 35(7):782-6. PubMed ID: 27088585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons from the US rotavirus vaccination program.
    Glass RI; Patel M; Parashar U
    JAMA; 2011 Oct; 306(15):1701-2. PubMed ID: 22009102
    [No Abstract]   [Full Text] [Related]  

  • 20. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(36):893-7. PubMed ID: 16163262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.